Evolving Aspects of Mesothelioma Carcinogenesis: SV40 and Genetic Predisposition  by Carbone, Michele & Pass, Harvey I.
MINI-SYMPOSIUM
Evolving Aspects of Mesothelioma Carcinogenesis: SV40
and Genetic Predisposition
Michele Carbone, MD, PhD,* and Harvey I. Pass, MD†
(J Thorac Oncol. 2006;1: 169–171)
Malignant mesothelioma is characterized by a long la-tency from the time of exposure to asbestos to the onset
of disease, which suggests that multiple somatic genetic
events are required for tumorigenic conversion of a normal
mesothelial cell. Epidemiological studies have established
that exposure to asbestos fibers is the primary cause of
malignant mesothelioma1,2, and recent investigations have
implicated simian virus 40 (SV40) and genetic predisposition
in the etiology of some malignant mesothelioma.
SV40
SV40 is a DNA tumor virus that is endogenous in
rhesus monkeys and is now widespread among the human
population. The modes by which the virus was transferred
from monkey to human are uncertain, but it is possible that
the bulk of this transfer may have occurred from 1954 to 1963
through SV40-contaminated polio vaccines administered
worldwide.3 SV40 can be excreted via human feces, breast
milk, and semen4, and Butel et al.5 and Butel and Lednicky 6
have reported that 5.9% of 377 Texas children born between
1980 and 1995 had SV40-neutralizing antibodies.
SV40 produces two oncogenic proteins, the large and
small t antigens.2,4 The large T antigen (Tag) is capable of
inducing structural and numerical chromosomal alterations.
Tag also induces insulin-like growth factor expression and
inhibits p53 and the pRb family, and it induces c-met activity
to stimulate cell proliferation.3,4 The small t antigen (tag)
inhibits cellular phosphatase 2A, stimulates MAP kinase and
AP-1 activity, and works with Tag to bind and inhibit p53 and
pRb.3 The combined activity of both the large Tag and the
small tag induce Notch-1 and telomerase activity, which are
required for malignant transformation and immortalization.7,8
Analysis of human mesotheliomas for the virus re-
vealed that SV40 sequences were present in 29 of 48 human
mesothelioma samples (60%). Sequence analysis confirmed
that the virus detected was SV40.9 Polymerase chain reaction
analysis, mRNA in situ hybridization, microdissection, and
immunostaining techniques used in several studies have also
shown that SV40 sequences and antigens are found in tumor
cells but not in the normal adjacent tissue.2,4 Although more
than 60 laboratories have found SV40 in human mesothelio-
mas and other tumors, the virus was not detected in Finnish,
Austrian, and Turkish mesothelioma specimens,2–4 which
suggests that the presence of SV40 in human tumors may be
influenced by geographic factors. One of these factors may be
related to polio vaccine distribution, because SV40-contam-
inated polio vaccines were not administered in Finland,
Austria, and Turkey.2,3 Three independent panels have re-
viewed and confirmed the association of SV40 with human
tumors, especially mesothelioma.10–12
Human mesothelial cells are unusually susceptible to
SV40 infection compared with fibroblasts.3–5 In mesothelial
cells, Tag binds p53 and inhibits its tumor suppressor activity.
At the same time, the interaction inhibits the ability of the
virus to replicate, which ultimately leads to prolonged expo-
sure of the cell to the mutagenic effects of Tag. This may be
responsible for the high rate of transformation observed in
SV40-infected mesothelial cells and may explain the ability
of SV40 to preferentially induce mesotheliomas in hamsters
and its presence in most human mesotheliomas.5
Overall, substantial evidence supports a role for SV40
in mesothelioma pathogenesis. SV40 is present in human
mesotheliomas, where it is specifically found in the tumor
cells and not in the normal surrounding tissues. Within these
tumor cells, SV40 binds and inactivates essential tumor
suppressor gene products, including p53 and pRb, and stim-
ulates met, Notch-1, and telomerase activity. Moreover,
SV40 causes promoter methylation and, thus, inactivation of
the tumor suppressor RASSF1A, which causes a more ag-
gressive tumor phenotype.13 In animals, SV40 is a potent
carcinogen, causing mesotheliomas in 100% of hamsters after
intrapleural injection.
Several arguments about the precise role of SV40 in the
pathogenesis of all mesotheliomas remain. First, the possible
impact of SV40 on overall mesothelioma incidence has not
been determined. This has been limited by the fact that
studies comparing mesothelioma incidence in SV40-infected
cohorts versus non-infected cohorts are unreliable, because it
seems impossible to identify infected and uninfected co-
horts.12 Second, most mesotheliomas develop in people who
have been exposed to asbestos, some of whom are SV40-
negative. It may be difficult to separate the effect of SV40
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and asbestos in individuals exposed to both carcinogens.
Third, SV40-infected mesothelial cells should express viral
antigens that would be an easy target for the immune system.
Why they would not be eliminated before tumor development
is unclear, but the immunosuppressive effects of asbestos
may play a role. Fourth, SV40 was not found in mesotheli-
omas in certain countries,3 and it is not found in all American
mesotheliomas, which indicates that, like asbestos, it is not
always necessary for mesothelioma development.
It is unlikely that SV40 acts alone in mesothelioma
development, as most cancers are multifactorial and most
mesotheliomas occur in asbestos-exposed individuals. In-
stead, it seems more likely that asbestos and SV40 may act as
co-carcinogens in the development of some mesotheliomas.
SV40 and asbestos have been shown to act as co-carcinogens
in vitro4 and more recently in animal experiments (Carbone et
al., unpublished observations). The possibility that SV40 and
asbestos may also act as co-carcinogens in humans is impor-
tant because SV40 is frequently found in mesothelioma
patients with a history of asbestos exposure. Additional
co-factors, such as radiation exposure or genetics, may also
act in conjunction with SV40, asbestos, or both. Future
studies may be able to target Tag as an immunogen to treat
mesothelioma with immunotherapy.
GENETIC PREDISPOSITION
Intriguing epidemiologic data imply that genetic pre-
disposition may play an important role in determining indi-
vidual susceptibility to mineral fiber carcinogenesis and to the
development of mesothelioma. In villages built with stones
mined from the nearby natural caves in Cappadocia, a region
in Central Anatolia, Turkey, at least 50% of deaths are caused
by malignant mesothelioma.13–17 When Baris et al.13 discov-
ered a very high incidence of mesothelioma in the village of
Karain, scientists looked for asbestos, and some asbestos was
found;18 however, additional studies demonstrated that asbes-
tos is omnipresent in Cappadocia because it is a natural
component of that volcanic terrain and because asbestos-
tremolite–based stucco has been widely used in building
construction in all Cappadocian villages.14–17,19 Hence, as-
bestos could not account for the uniquely high incidence of
mesotheliomas in these three villages.14–17,19 Another type of
mineral fiber, erionite, which had been detected in the lungs
of several villagers, was suspected as causative agent.14–17,19
Erionite is a type of fibrous zeolite commonly found in the
stones of the houses of Karain, Sarihidir, and Tuzkoy,2,17,19,20
which, when injected intrapleurally into animals, caused
mesothelioma.21 Erionite, therefore, seemed much more po-
tent than asbestos in causing mesothelioma because more
than half of the villagers died of this disease,17,19,22 and
erionite is thought to be one of the most potent human
carcinogens.20 Studies tried to link erionite to other human
tumors, but there were no significant differences in the
incidence of any other tumor types in these two villages
compared with the rest of Turkey.2 Why such a potent
carcinogen would specifically cause mesothelioma was un-
known, and why approximately 50% of villagers seemed to
experience no consequence from exposure to such a potent
carcinogen was also unknown.
However, closer observation revealed that mesothelio-
mas only occurred in certain homes and not in others (homes
in these areas are inhabited by multiple generations and
passed down), even though all homes contained similar
amounts of erionite according to recent mineralogical analy-
sis.2,23 Furthermore, in the nearby village of Karlik, where
homes are built from the same materials and contain the same
types of erionite fibers, only one mesothelioma had been
known to occur, which was in a woman who had migrated
from Karain.2,23 Further analysis of pedigrees of families who
lived in homes in which mesotheliomas occurred showed that
these mesotheliomas seemed to be inherited in an autosomal
dominant pattern. Approximately 50% of descendents of
affected parents developed mesotheliomas. When members
of unaffected families married into affected families, 50% of
their descendents also developed mesotheliomas.2,23 Whether
genetics alone or in conjunction with erionite are responsible
for these mesotheliomas remains unknown, but clearly genet-
ics is a key factor because mesotheliomas do not develop in
non-affected families regardless of environmental exposure.
The study of these villages is part of an international Amer-
ican Cancer Society Grant funded for the purpose of possibly
detecting a specific tumor suppressor gene for mesothelioma.
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